Holocene Advisors LP Grows Stock Holdings in Chemed Co. (NYSE:CHE)

Holocene Advisors LP raised its position in shares of Chemed Co. (NYSE:CHE) by 14.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,470 shares of the company’s stock after buying an additional 1,353 shares during the period. Holocene Advisors LP owned about 0.07% of Chemed worth $6,292,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. GAMMA Investing LLC boosted its holdings in Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust purchased a new position in Chemed in the third quarter valued at $61,000. Mather Group LLC. boosted its holdings in Chemed by 60.5% in the second quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after purchasing an additional 69 shares during the period. Quarry LP boosted its holdings in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares during the period. Finally, Sound Income Strategies LLC purchased a new stake in Chemed during the 3rd quarter worth about $201,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on CHE shares. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,845 shares of company stock worth $3,978,798. Corporate insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $569.80 on Thursday. The business has a 50-day moving average of $576.77 and a two-hundred day moving average of $565.09. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62. The company has a market capitalization of $8.58 billion, a price-to-earnings ratio of 28.79, a price-to-earnings-growth ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter last year, the firm posted $5.32 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, equities research analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.